首页> 中文期刊> 《中国医药导报》 >微卡注射液联合左氧氟沙星治疗耐多药肺结核临床观察

微卡注射液联合左氧氟沙星治疗耐多药肺结核临床观察

         

摘要

Objective: To explore the clinical efficacy of microcalorie chems injection combined with Levofloxacin on mul ti-drug resistant pulmonary tuberculosis. Methods: 81 cases with multi-drug resistant pulmonary tuberculosis were selected from December 2009 to December 2010 and randomly divided into observation group and control group. The chemotherapy regimen of 6AM..Pa.Z.Clr (E)/18.Pa.Z. Clr (E)was used to control group. microcalorie chems combined with Levofloxacin was given to observation group on the base of control group, the course was six months in two groups. Results: The symptoms improvement rate, bacterial negative rate, the efficacy rate of X- ray and cavity healing rate in observation group compared with those in control goup,there all were statistical difference (all P<0.05). Conclusion: Microcalorie chems combined with Levofloxacin can improve the symptoms of the patients with multi-drug resistant pulmonary tuberculosis,the clinical efficacy is significant.%目的:探讨左氧氟沙星联合微卡注射液治疗耐多药肺结核的临床效果.方法:选择我院2009年12月~2010年12月耐多药肺结核患者81例,将以上患者随机分为观察组和对照组.对照组患者应用6AM..Pa.Z.Clr(E)/18.Pa.Z.Clr(E)化疗,观察组在对照化疗的基础上给予微卡注射液和左氧氟沙星.两组患者观察期为6个月.结果:观察组临床症状改善率、细菌转阴率、X线疗效总有效率、空洞愈合率显著高于对照组,差异有统计学意义(P<0.05).结论:微卡注射液联合左氧氟沙星能够显著改善耐多药肺结核患者临床症状,临床效果显著.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号